Preventive administration of rapamycin permits to decrease severity of EAM. by Nicolas Prevel (483113)

Vinpocetine inhibits carrageenan-induced decrease in antioxidant capacity. by Kenji W. Ruiz-Miyazawa (714809)

Single mutations decrease drug susceptibility and increase fitness. by Linda L. Marcusson (261125)

Retinoic acid alleviates decreases of phospho-Akt and phospho-Bad expression caused by MCAO damage. by Ju-Bin Kang (16021324)

IDH1 R132H mutant stable cells have decreased NADPH and GSH. by Huixia Zhu (3615314)

Excitotoxicity-induced decrease in GAD65/67 activity. by Márcio S. Baptista (365618)

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)

Rh-endostatin decreases microvascular density (MVD) and promotes vessel normalization of A549 lung carcinoma. by Shujing Shi (422263)

DataSheet_2_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

“…Therefore, we designed a cyclic peptide PROTAC to achieve this efficient anti-PD-L1 effect.…”

DataSheet_1_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

“…Therefore, we designed a cyclic peptide PROTAC to achieve this efficient anti-PD-L1 effect.…”

RyhB decreases Nuo and Sdh enzymatic activities. by Sylvia Chareyre (6619325)

Senescent endothelial cells of hippocampus are decreased by treatment with DHT. by Hidetaka Ota (189433)

Dex treatemnt decreases body and muscle weight in mice. by Yanjun Dong (389082)

Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

“…We normalised by the trial duration of 25 price, instead of simply normalizing by the price, to emphasise that <i>TA</i> is a macroscopic quantitity and to be consistent with the procedure in the example data <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1003894#pcbi.1003894.s001" target="_blank">Figure S1</a>.…”

CCN3 protein decreases β-cell proliferation. by Renée Paradis (326111)

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)

Effects of siRNA TMPRSS2-ERG III and IV on cell death pathways. by Giorgia Urbinati (554921)

Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…At each interval, we obtained (<b>A</b>) microscopic images (original magnification: 100x), (<b>B</b>) AFM topography images (scan size <b>B1</b>, 50 µm; <b>B2</b>, 20 µm; <b>B3</b>, 33.3 µm), and (<b>C</b>) height measurements at the cross section of an individual cell. …”

MβCD treatment decreases neuroglian stabilization. by Nicholas J. Gibson (173220)

2-NBDG₆₀ is sensitive to a decrease in blood glucose levels. by Narasimhan Rajaram (474255)